Iterum Therapeutics PLC (NAS:ITRM)
$ 1.3 -0.03 (-2.22%) Market Cap: 21.52 Mil Enterprise Value: 24.32 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 35/100

Q4 2021 Iterum Therapeutics PLC Earnings Call Transcript

Mar 28, 2022 / 12:30PM GMT
Release Date Price: $5.76 (-14.27%)
Operator

Hello, and welcome to the Iterum Therapeutics Fourth Quarter and Full Year 2021 Financial Results Call. My name is Alex, and I'll be coordinating the call today. (Operator Instructions) I will now hand over to your host, Louise Barrett, Senior Vice President of Legal Affairs. Over to you, Louise.

Louise Barrett
Iterum Therapeutics plc - SVP of Legal Affairs & Secretary

Thanks, Alex. Good morning, and welcome to Iterum Therapeutics Fourth Quarter and Full Year 2021 Financial Results and Business Update Conference Call. A press release with our fourth quarter and full year results, was issued earlier this morning and can be found on our website.

We are joined this morning by Corey Fishman, our CEO; and Judy Matthews, our CFO. Corey will provide some opening remarks. Judy will provide details on our financial results, and then we will open the lines for Q&A.

Before we begin, I would just like to remind you that this call will contain forward-looking statements concerning our plans, strategies and prospects for our business, including

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot